Literature DB >> 22410822

Cool seasons are related to poor prognosis in patients with infective endocarditis.

Su-Jung Chen1, Tze-Fan Chao, Yenn-Jiang Lin, Li-Wei Lo, Yu-Feng Hu, Ta-Chuan Tuan, Tsui-Lieh Hsu, Wen-Chung Yu, Hsin-Bang Leu, Shih-Lin Chang, Shih-Ann Chen.   

Abstract

Many cardiac diseases demonstrate seasonal variations in the incidence and mortality. This study was designed to investigate whether the mortality of infective endocarditis (IE) was higher in cool seasons and to evaluate the effects of cool climate for IE. We enrolled 100 IE patients with vegetations in our hospital. The temperatures of the IE episodes were defined as the monthly average temperatures of the admission days. The average temperatures in the cool (fall/winter) and warm seasons (spring/summer) were 19.2°C and 27.6°C, respectively. In addition, patients admitted with the diagnosis of IE were identified from the National Health Insurance Research Database (NHIRD) and the in-hospital mortality rates in cool and warm seasons were compared to validate the findings derived from the data of our hospital. The mortality rate for IE was significantly higher in fall/winter than in spring/summer which presents consistently in the patient population of our hospital (32.7% versus 12.5%, p = 0.017) and from NHIRD (10.4% versus 4.6%, p = 0.019). IE episodes which occurred during cool seasons presented with a higher rate of heart failure (44.2% versus 22.9%, p = 0.025) and D-dimer level (5.5 ± 3.8 versus 2.4 ± 1.8 μg/ml, p = 0.017) at admission than that of warm seasons. These results may reflect the impact of temperatures during the pre-hospitalized period on the disease process. In the multivariate analysis, Staphylococcal infection, left ventricular hypertrophy, left ventricular systolic dysfunction and temperature were the independent predictors of mortalities in IE patients.

Entities:  

Mesh:

Year:  2012        PMID: 22410822     DOI: 10.1007/s00484-011-0507-5

Source DB:  PubMed          Journal:  Int J Biometeorol        ISSN: 0020-7128            Impact factor:   3.787


  30 in total

1.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Authors:  J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey
Journal:  Clin Infect Dis       Date:  2000-04-03       Impact factor: 9.079

2.  Seasonal diagnosis of echocardiographically demonstrated endocarditis.

Authors:  Robert S Finkelhor; Grace Cater; Amir Qureshi; Douglas Einstadter; Michelle T Hecker; Georgene Bosich
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

3.  Increased winter mortality from acute myocardial infarction and stroke: the effect of age.

Authors:  T Sheth; C Nair; J Muller; S Yusuf
Journal:  J Am Coll Cardiol       Date:  1999-06       Impact factor: 24.094

Review 4.  Pathogenesis of multiple organ dysfunction syndrome--endotoxin, inflammatory cells, and their mediators: cytokines and reactive oxygen species.

Authors:  R V Maier
Journal:  Surg Infect (Larchmt)       Date:  2000       Impact factor: 2.150

5.  Seasonal pattern of incidence and case fatality of acute myocardial infarction in a Japanese population (from the Takashima AMI Registry, 1988 to 2003).

Authors:  Nahid Rumana; Yoshikuni Kita; Tanvir Chowdhury Turin; Yoshitaka Murakami; Hideki Sugihara; Yutaka Morita; Nobuyoshi Tomioka; Akira Okayama; Yasuyuki Nakamura; Hirotsugu Ueshima
Journal:  Am J Cardiol       Date:  2008-09-05       Impact factor: 2.778

6.  Does neuroimmune dysfunction mediate seasonal mood changes in winter depression?

Authors:  Raymond W Lam; Cai Song; Lakshmi N Yatham
Journal:  Med Hypotheses       Date:  2004       Impact factor: 1.538

7.  Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer.

Authors:  Gilbert Habib; Bruno Hoen; Pilar Tornos; Franck Thuny; Bernard Prendergast; Isidre Vilacosta; Philippe Moreillon; Manuel de Jesus Antunes; Ulf Thilen; John Lekakis; Maria Lengyel; Ludwig Müller; Christoph K Naber; Petros Nihoyannopoulos; Anton Moritz; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

Review 8.  The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome.

Authors:  Houli Wang; Sui Ma
Journal:  Am J Emerg Med       Date:  2008-07       Impact factor: 2.469

9.  Prognostic value of a new quantitative D-dimer test in critically ill patients 24 and 48 h following admission to the intensive care unit.

Authors:  David Shitrit; Gabriel Izbicki; Ariella Bar-Gil Shitrit; Mordechai R Kramer; Bernard Rudensky; Jaqueline Sulkes; Moshe Hersch
Journal:  Blood Coagul Fibrinolysis       Date:  2004-01       Impact factor: 1.276

10.  Stroke case fatality shows seasonal variation regardless of risk factor status in a Japanese population: 15-year results from the Takashima Stroke Registry.

Authors:  Tanvir Chowdhury Turin; Yoshikuni Kita; Nahid Rumana; Yoshitaka Murakami; Masaharu Ichikawa; Hideki Sugihara; Yutaka Morita; Nobuyoshi Tomioka; Akira Okayama; Yasuyuki Nakamura; Robert D Abbott; Hirotsugu Ueshima
Journal:  Neuroepidemiology       Date:  2008-11-12       Impact factor: 3.282

View more
  2 in total

Review 1.  The causative agents in infective endocarditis: a systematic review comprising 33,214 cases.

Authors:  Christiana T Vogkou; Nikolaos I Vlachogiannis; Leonidas Palaiodimos; Antonis A Kousoulis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-11       Impact factor: 3.267

2.  Relationships of physiologically equivalent temperature and hospital admissions due to I30-I51 other forms of heart disease in Germany in 2009-2011.

Authors:  Ivy Shiue; David R Perkins; Nick Bearman
Journal:  Environ Sci Pollut Res Int       Date:  2015-12-01       Impact factor: 4.223

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.